MelphalanBoronic AcidsPyrazinesMultiple MyelomaProteasome InhibitorsChemotherapy, Cancer, Regional PerfusionAntineoplastic Agents, AlkylatingProtease InhibitorsAntineoplastic AgentsThalidomideAntineoplastic Combined Chemotherapy ProtocolsTransplantation, AutologousDrug SynergismProteasome Endopeptidase ComplexMyeloablative AgonistsDexamethasonePrednisoneDrug Resistance, NeoplasmAmyloidosisCell Line, TumorHematopoietic Stem Cell TransplantationTransplantation ConditioningApoptosisTreatment OutcomeCarmustineCombined Modality TherapyCyclophosphamideDose-Response Relationship, DrugVincristineDrug Screening Assays, AntitumorDoxorubicinDrug Administration ScheduleLymphoma, Mantle-CellStem Cell TransplantationMisonidazoleMaintenance ChemotherapyButhionine SulfoximineCell SurvivalMethionine SulfoximineDisease-Free SurvivalRecurrenceRemission InductionThiotepaMaximum Tolerated DoseSalvage TherapyMelanomaXenograft Model Antitumor AssaysAlkylating AgentsBusulfanNitrogen Mustard CompoundsChlorambucilSurvival RateSurvival AnalysisLeukemia, Plasma CellVidarabineTumor Cells, CulturedExtremitiesBone Marrow TransplantationDrug ResistanceSemustineRats, NudePlasma CellsPeripheral Blood Stem Cell TransplantationLomustineEtoposideDrug Therapy, CombinationNeoplasmsWhole-Body IrradiationTime FactorsPeripheral Nervous System DiseasesHyperthermia, InducedAlfaxalone Alfadolone MixtureNF-kappa BMyeloma ProteinsSarcomaHematologic DiseasesFlunarizinePlasmacytomaMice, SCIDImmunoglobulin Light ChainsStomatitisCell ProliferationLactate DehydrogenasesCytarabineNitroimidazolesSarcoma, Experimental